Insulin receptor- and nonreceptor-controlled cellular substrate processing. A review of clinical studies in the isolated human adipocyte model.
D019325:3-O-Methylglucose; D000273:Adipose Tissue / Q000378:metabolism*; D001692:Biological Transport; D001773:Blood Cells / Q000378:metabolism; D002110:Caffeine / Q000494:pharmacology; D002478:Cells, Cultured; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D005215:Fasting; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000097:blood / Q000502:physiology*; D007330:Insulin Antibodies / Q000032:analysis; D007333:Insulin Resistance; D050356:Lipid Metabolism; D008066:Lipolysis / Q000187:drug effects; D008297:Male; D008757:Methylglucosides / Q000378:metabolism; D008954:Models, Biological; D009638:Norepinephrine / Q000494:pharmacology; D009765:Obesity / Q000378:metabolism; D010920:Placenta / Q000378:metabolism; D011972:Receptor, Insulin / Q000502:physiology*; D012737:Sex Factors
D007328:Insulin; D007330:Insulin Antibodies; D008757:Methylglucosides; D019325:3-O-Methylglucose; D002110:Caffeine; D011972:Receptor, Insulin; D005947:Glucose; D009638:Norepinephrine